lo li pharma international s r l
Loli Pharma International
Build long-lasting business partnerships Lo.Li. Pharma International is the global subsidiary of Lo.Li. Pharma Group, an Italian leader in the research and development of scientifically validated health solutions. We operate through a dedicated B2B model, collaborating with a trusted network of local partners who choose to bring our products to their national markets. Thanks to […]
- Type
- Manufacturer
- Location
- Rome, Italy
- Website
- https://www.lolipharmainternational.com/
- Categories
- Pharmaceutical Manufacturing, Industrial Machinery, Medical & Healthcare Supplies
Listed in a source registry
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- debarment-clear (green), checked 2026-08-09 OpenSanctions
- sanctions-clear (green), checked 2026-08-09 OpenSanctions
- export-registered (green), checked 2026-07-30 EU EORI validation (European Commission)
- vat-valid (green), checked 2026-08-01 VIES (European Commission)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Machinery sold in the EU needs CE marking with a declaration of conformity under the EU machinery rules. European Commission
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)
- No public registry exists for certificates of this kind in this sector: conformity is declared by the manufacturer. European Commission: CE marking, manufacturer's conformity assessment